• Clinical Trials - Liver cancer

    Study Objective Contact
    A Humanitarian Device Exemption Treatment Protocol Of Therasphere® For Treatment Of Unresectable Hepatocellular Carcinoma [LCID Study Number: 2009-043] Protocol Of Therasphere® For Treatment Of Unresectable Hepatocellular Carcinoma. TheraSphere is a low toxicity, targeted liver cancer therapy that consists of millions of tiny radiosactive glass beads about a third of the width of a human hair that are delivered directly to liver tumors. Principal Investigator(s):
    Sebastian Flacke, MD, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nanette Matrullo.
    Molecular Analysis of Cancer [LCID Study Number: 2011-048] The purpose of this research is to discover molecular changes involved in cancer. We hope that a better understanding of these changes can improve cancer management. This research may include genetic and/or genomic analysis (tests to determine and compare your genetic sequence, or DNA). Some of the tissue we collect for our research may be submitted to the National Cancer Institute Cancer Genome Atlas Project. The goal of this project is to determine the genomic changes involved in more than 20 types of human cancer. Principal Investigator(s):
    Kimberly R. Christ, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Doreen L. Browne, ,CCRP,
    Jane S. Nalwalk,
    Linda M. Topjian.